Preclinical studies described that activated NOTCH1 gets involved in tumorigenesis, proliferation and survival of NSCLC models through collaborating with Myc or modulating the expression of epidermal growth factor receptor (EGFR)[15, 16]. Here, EGFR is linked to non-small cell lung carcinoma.